- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04208269
A Multilevel Approach to Increasing HPV Vaccine Initiation Among Adolescents - Part 3
May 15, 2020 updated by: University of Florida
Our project will assess the feasibility and estimate preliminary efficacy of a multilevel intervention to improve HPV vaccine series initiation among adolescents in Medicaid and CHIP.
The investigators will use two intervention components: postcards and an iPad survey system.
To estimate efficacy the investigators will select potential participants from Florida Medicaid and CHIP.
The investigators will assess their claims for the HPV vaccine before and after the intervention.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5663
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610
- University of Florida
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
11 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Enrolled in Florida Medicaid
- Not initiated the HPV vaccine series at the start of the study period.
Exclusion Criteria:
- Anyone who has a severe (life threatening) allergy to any component of HPV vaccine, esp yeast
- Pregnant
- Not enrolled in Florida Medicaid
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard care
|
|
Active Comparator: Postcard campaign
|
Post card sent to parent only
|
Active Comparator: Provider-only intervention
|
Accessed by adolescent and provider only
|
Active Comparator: Patient and provider intervention
|
Post card sent to parent only
Accessed by adolescent and provider only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The number of participants receiving HPV vaccine
Time Frame: Up to 5 months
|
The percent age eligible participants who initiate HPV vaccination.
|
Up to 5 months
|
Number of preventive care visits
Time Frame: Up to 3 months
|
The percent age eligible participants received a preventive care visit
|
Up to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Stephanie Staras, PhD, University of Florida
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
March 30, 2015
Study Registration Dates
First Submitted
December 19, 2019
First Submitted That Met QC Criteria
December 19, 2019
First Posted (Actual)
December 23, 2019
Study Record Updates
Last Update Posted (Actual)
May 19, 2020
Last Update Submitted That Met QC Criteria
May 15, 2020
Last Verified
May 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201200143
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Human Papilloma Virus
-
Regenstrief Institute, Inc.Merck Sharp & Dohme LLCCompletedCervical Cancer | Human Papilloma Virus Infection Type 11 | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18 | Human Papilloma Virus Infection Type 6United States
-
Procare Health Iberia S.L.Adknoma Health ResearchCompletedHuman Papilloma Virus Infection | Human Papilloma Virus | Cervix LesionSpain
-
Emory UniversityNational Institute of Nursing Research (NINR)RecruitingHuman Papilloma Virus | Human Papilloma Virus VaccineUnited States
-
The Behavioural Insights TeamUNICEF; National Center for Disease Control and Public Health, Georgia; Information...Not yet recruitingHPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine
-
Xiamen Innovax Biotech Co., LtdZhejiang Provincial Center for Disease Control and PreventionActive, not recruitingHuman Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18 | Hepatitis E Virus InfectionChina
-
Universitair Ziekenhuis BrusselRecruiting
-
Universiti Sains MalaysiaRecruitingHuman Papilloma Virus InfectionMalaysia
-
Universiteit AntwerpenCompletedHuman Papilloma Virus InfectionBelgium
-
Gen-Probe, IncorporatedCompletedHuman Papilloma Virus InfectionUnited States
-
Shanghai Zerun Biotechnology Co.,LtdGuangxi Center for Disease Control and PreventionCompletedCervical Intraepithelial Neoplasia | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18
Clinical Trials on postcard campaign
-
US Department of Veterans AffairsCompletedPacemaker DDD | Adherence, Patient | ICDUnited States
-
Azienda Ospedaliero-Universitaria di ParmaCompleted
-
Inter-American Development BankBusara Center for Behavioral EconomicsNot yet recruiting
-
Kaiser PermanenteCompletedChronic Obstructive Pulmonary Disease | AsthmaUnited States
-
British Columbia Cancer AgencyCanadian Breast Cancer FoundationCompleted
-
Geisinger ClinicRecruiting
-
Geisinger ClinicCompletedHealth Promotion | Prevention | Risk Reduction Behavior | TelehealthUnited States
-
Tufts UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHealth Communication
-
National Taiwan University HospitalRecruitingStroke, CardiovascularTaiwan
-
University of North Carolina, Chapel HillLondon School of Hygiene and Tropical Medicine; National Institute of Allergy... and other collaboratorsCompleted